Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,289,000 | 8,015,000 | 3,547,000 | 9,007,000 | 9,303,000 |
| Marketable Securities | 772,000 | 770,000 | 196,000 | 467,000 | 486,000 |
| Receivables | 5,384,000 | 5,780,000 | 5,793,000 | 5,841,000 | 5,088,000 |
| Inventories | 1,605,000 | 1,786,000 | 1,580,000 | 1,738,000 | 1,605,000 |
| TOTAL | $16,945,000 | $18,465,000 | $13,845,000 | $20,444,000 | $21,223,000 |
| Non-Current Assets | |||||
| PPE Net | 2,883,000 | 2,950,000 | 2,787,000 | 2,828,000 | 2,803,000 |
| Investments And Advances | 1,420,000 | 1,463,000 | 1,505,000 | 2,057,000 | 2,090,000 |
| Intangibles | 36,896,000 | 42,343,000 | 42,595,000 | 43,110,000 | 43,344,000 |
| Other Non-Current Assets | 1,208,000 | 943,000 | 909,000 | 903,000 | 1,326,000 |
| TOTAL | $42,407,000 | $47,699,000 | $47,796,000 | $48,898,000 | $49,563,000 |
| Total Assets | $59,352,000 | $66,164,000 | $61,641,000 | $69,342,000 | $70,786,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,308,000 | 4,021,000 | 6,530,000 | 6,381,000 | 6,415,000 |
| Accounts payable and accrued liabilities | 11,931,000 | 11,366,000 | 10,694,000 | 10,677,000 | 10,226,000 |
| TOTAL | $17,239,000 | $15,387,000 | $17,224,000 | $17,058,000 | $16,641,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 35,002,000 | 36,487,000 | 30,579,000 | 30,906,000 | 30,953,000 |
| Other Non-Current Liabilities | 14,490,000 | 15,721,000 | 15,543,000 | 15,521,000 | 15,605,000 |
| TOTAL | $50,559,000 | $53,698,000 | $47,792,000 | $48,731,000 | $49,048,000 |
| Total Liabilities | $67,798,000 | $69,085,000 | $65,016,000 | $65,789,000 | $65,689,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,475,084 | 1,504,216 | 1,514,273 | 1,586,879 | 1,587,973 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 3,368,000 | 6,789,000 | 5,495,000 | 4,977,000 | 5,459,000 |
| Other shareholders' equity | -2,480,000 | -2,559,000 | -2,639,000 | -2,630,000 | -2,727,000 |
| TOTAL | $-8,446,000 | $-2,921,000 | $-3,375,000 | $3,553,000 | $5,097,000 |
| Total Liabilities And Equity | $59,352,000 | $66,164,000 | $61,641,000 | $69,342,000 | $70,786,000 |